Clinical Trials Directory

Trials / Completed

CompletedNCT02839551

Optimal Doses for Drug Provocation Tests to Beta-lactams

Optimal Step Doses for Drug Provocation Tests to Prove Beta-lactam Hypersensitivity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,252 (actual)
Sponsor
University Hospital, Montpellier · Academic / Other
Sex
Female
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Drug provocation tests (DPT) are widely in case of suspicion of drug hypersensitivity (and in the absence of contraindications), but there are no standardized protocols and most groups use hypothesis (clinically-driven) protocols. investigators used 20 year experience in drug hypersensitivity to analyse retrospectively 171 patients (accounting for 182 positive DPT to beta-lactams). Using survival analysis, they identified optimal doses to include in a data-driven protocol. This data-driven protocol will be applied to new prospective patients, to test its safety and benefits (gain in time, hospital and patient benefits).

Conditions

Interventions

TypeNameDescription
PROCEDUREsimplified drug provocation testAssessment of the Hypersensitivity to betalactams by simplified drug provocation test

Timeline

Start date
2016-05-04
Primary completion
2021-11-16
Completion
2021-11-16
First posted
2016-07-21
Last updated
2025-09-30

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02839551. Inclusion in this directory is not an endorsement.

Optimal Doses for Drug Provocation Tests to Beta-lactams (NCT02839551) · Clinical Trials Directory